← All decks

Dermatology

Lipodystrophies

Built from Dermatology, 5th Edition

The first 25 slides of Lipodystrophies
The first 25 slides, exactly as they appear. The full deck has 122 content slides.

What’s inside

14 sections · 122 slides

  1. 01

    What Lipodystrophy Is

    Selective fat loss, its patterns, and why fat loss matters

    • Definition of lipodystrophy
    • Lipoatrophy vs lipodystrophy vs lipohypertrophy
    • Why fat loss causes disease
    • Two axes of classification
    • Distribution of fat loss and fat gain
    • Reading the classification table
    • Lipodystrophy syndromes: quick-reference
    • Lipodystrophy syndromes: quick-reference (continued)

    8 slides

  2. 02

    Pathogenesis

    Why fat cells fail, and how that drives metabolic disease

    • Fat as an endocrine organ
    • Fat cell hormones and metabolic disease
    • A common pathway: fat cells that cannot store fat
    • From fat cell failure to metabolic disease
    • Adiponectin: the protective fat hormone
    • Leptin replacement reverses insulin resistance

    6 slides

  3. 03

    Congenital Generalized Lipodystrophy

    Berardinelli-Seip syndrome: near-total fat loss from birth

    • Congenital generalized lipodystrophy: overview
    • CGL types 1 and 2: enzyme and lipid droplet defects
    • CGL types 3 and 4: caveolae defects
    • Why the four types look different
    • CGL: cadaveric facies and muscular build
    • CGL: anabolic features and metabolic timeline
    • CGL: organ complications and outcome
    • CGL: how the four types differ in severity
    • Features of congenital generalized lipodystrophy
    • Features of congenital generalized lipodystrophy
    • Features of congenital generalized lipodystrophy (continued)
    • Extensive acanthosis nigricans and lipodystrophy in CGL
    • CGL with acanthosis nigricans and clitoromegaly
    • Extensive acanthosis nigricans in CGL

    14 slides

  4. 04

    Familial Partial Lipodystrophy

    Later-onset, limb-predominant inherited fat loss

    • Familial partial lipodystrophy: overview
    • FPLD subtypes by gene
    • FPLD2: the LMNA gene and nuclear lamina
    • LMNA mutations cause a family of diseases
    • FPLD3: the PPARG gene
    • FPLD4 and the rare FPLD5-7 subtypes
    • Familial partial lipodystrophy with mandibuloacral dysplasia
    • FPLD2: what fat loss looks like
    • Metabolic disturbances in FPLD
    • Skin and gynecologic findings in FPLD
    • Clinical features of FPLD with mandibuloacral dysplasia

    11 slides

  5. 05

    Other Genetic Lipodystrophy Syndromes

    Proteasome disease and a childhood panniculitis syndrome

    • Proteasome-associated autoinflammatory syndromes
    • PRAAS: lipodystrophy and pathology
    • Recurrent lipoatrophic panniculitis of children

    3 slides

  6. 06

    Acquired Generalized Lipodystrophy

    Lawrence syndrome: rare, non-genetic, widespread fat loss

    • Acquired generalized lipodystrophy: overview
    • What comes before AGL
    • AGL: three subtypes
    • AGL diagnostic criteria and subtypes
    • Acquired generalized lipodystrophy: diagnostic criteria and subtypes
    • AGL: clinical pattern of fat loss
    • AGL: panniculitis and disease course
    • Panniculitis preceding fat loss in AGL type 1
    • AGL: organ and gynecologic complications
    • AGL: skin findings and associated autoimmune disease

    10 slides

  7. 07

    Acquired Partial Lipodystrophy

    Barraquer-Simons syndrome: face-to-legs fat loss

    • Acquired partial lipodystrophy: overview
    • APL: pattern and timing of fat loss
    • APL: face-to-legs distribution
    • APL: another patient, with Sjogren syndrome
    • APL: how complement drives adipocyte loss
    • Complement-driven fat loss in APL
    • APL: kidney disease and infection risk
    • APL: other autoimmune associations and metabolic risk

    8 slides

  8. 08

    Localized Lipoatrophy

    The most common form: injections, pressure, trauma and panniculitis

    • Localized lipoatrophy: overview
    • Causes of localized lipoatrophy
    • Injected medications that can cause localized lipoatrophy
    • Insulin lipoatrophy
    • Lipoatrophia semicircularis (semicircular lipoatrophy)
    • Semicircular lipoatrophy: clinical course
    • Pressure lipoatrophy from crossing the legs
    • Involutional lipoatrophy
    • Corticosteroid-injection involutional lipoatrophy under the microscope
    • Atrophic connective tissue panniculitis and lupus panniculitis
    • Facial lipoatrophy from lupus panniculitis
    • Annular lipoatrophy
    • Lipodystrophia centrifugalis abdominalis infantilis
    • LCAI: clinical course and outcome
    • LCAI of the face
    • Other rare localized lipoatrophy patterns

    16 slides

  9. 09

    Lipohypertrophy

    When injected drugs cause fat to build up instead of shrink

    • Lipohypertrophy from insulin therapy
    • Other causes of lipohypertrophy
    • Causes of lipohypertrophy

    3 slides

  10. 10

    Pathology

    What lipodystrophy looks like under the microscope

    • General histologic picture
    • Two histologic patterns in acquired lipodystrophy
    • Involutional changes: two histologic subtypes
    • Localized lipodystrophy and LCAI under the microscope

    4 slides

  11. 11

    Differential Diagnosis

    Rare syndromes and conditions that can mimic lipodystrophy

    • Conditions that can mimic lipodystrophy
    • Leprechaunism and SHORT syndrome
    • Progeria-type syndromes, Cockayne syndrome, and AREDYLD
    • Differential diagnosis of partial and localized lipodystrophy
    • Poland syndrome and lipohypoplasia
    • The role of whole-body MRI

    6 slides

  12. 12

    Treatment

    Managing appearance, metabolism, and systemic complications

    • Three goals of lipodystrophy treatment
    • Cosmetic treatment options
    • Managing insulin injection-site lipoatrophy
    • Treating the metabolic derangements
    • Metreleptin: leptin replacement therapy
    • Treatment of acquired partial lipodystrophy
    • Newer drugs for severe high triglycerides

    7 slides

  13. 13

    Acquired Lipodystrophy From Other Causes

    HIV/ART, cancer drugs, POEMS syndrome, and stem cell transplant

    • HIV/ART-associated lipodystrophy: overview
    • Three mechanisms of ART-associated lipoatrophy
    • Mechanisms of ART-associated lipoatrophy in the tissue
    • Mechanisms of ART-associated lipoatrophy in detail
    • Mechanisms of antiretroviral therapy-associated lipoatrophy
    • Who is most at risk
    • Clinical findings in HIV/ART lipodystrophy
    • HIV/ART lipoatrophy of the face
    • HIV/ART lipoatrophy of the cheeks and legs
    • Temporal fat loss in HIV/ART-associated lipodystrophy
    • Drug-specific fat redistribution patterns
    • Metabolic and cardiovascular consequences
    • Immune checkpoint inhibitor-associated lipodystrophy
    • POEMS syndrome and allogeneic stem cell transplant

    14 slides

  14. 14

    Summary

    Key points to take away about lipodystrophy

    • Key points on lipodystrophy
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    12 slides